Dr Amanda Seabrook is a Consultant Endocrinologist. She manages all general endocrinology with particular expertise in thyroid (including thyroid cancer), pituitary, adrenal, parathyroid and metabolic bone disease. Amanda regularly attends and presents at local and international conferences to ensure she remains up to date with evidence-based medicine, thereby providing excellent care to her patients. She attends the Endocrine and Neuroendocrine Tumour Multidisciplinary Team Meetings at Royal North Shore Hospital. She is a member of the Endocrine Society of Australia and Endocrine Society of USA.
Amanda is currently undertaking her PhD through the Kolling Institute (University of Sydney) at Royal North Shore Hospital investigating genetic drivers contributing to the development of rare neuroendocrine tumours known as phaeochromocytoma and paraganglioma. Her research is supported by the Sydney Vital Research Scholarship. She has a specific interest in hereditary endocrine syndromes including Von Hippel Lindau Disease (VHL) and Multiple Endocrine Neoplasia 1 (MEN1) and multiple endocrine neoplasia 2 (MEN2). Amanda is a member of the eviQ cancer genetics reference committee where she contributes to the development of guidelines for genetic testing and surveillance of these conditions.
She undertook undergraduate medical training at the University of Western Australia, followed by physician training at St. Vincent’s Hospital, Melbourne and advanced training in endocrinology at The Canberra Hospital and Royal Prince Alfred Hospital, Sydney. She then undertook subspecialty training with the NSW Familial Cancer Service (Royal North Shore Hospital, Westmead Hospital).
|Areas of Expertise
- Thyroid Disease, including Thyroid Cancer
- Bone Disease and Calcium Disorders
- Pituitary Dysfunction
- Adrenal Disease
- Hereditary Endocrine Tumour Syndromes